Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens

Immunology

Volumn 102, Issue 1, 2001, Pages 67-76

  Kovarik, J ^a,b,c,d   Bozzotti, P ^a,b   Tougne, C ^a   Davis, H L ^a,b   Lambert, P H ^a,b   Krieg, A M ^a,b,c   Siegrist, C A ^a,b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF IOWA   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL POLYSACCHARIDE; CARRIER PROTEIN; CD4 ANTIGEN; EPITOPE; FICOLL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; OLIGONUCLEOTIDE; PICRIC ACID; TETANUS TOXOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL INTERACTION; CONTROLLED STUDY; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADJUVANTS, IMMUNOLOGIC; AGING; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, T-INDEPENDENT; B-LYMPHOCYTES; CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CPG ISLANDS; FICOLL; HAPTENS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDES; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; TRINITROBENZENES;

EID: 0035129151     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2001.01158.x     Document Type: Article

References (39)

1. The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect
2. Role of a nonimmunoglobulin cell surface determinant in the activation of B lymphocytes by thymus-independent antigens
3. T cell-independent antigens type 2
4. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells
5. Enhancement of T cell-independent immune responses in vivo by CD40 antibodies
6. Role of accessory cells in B cell activation. I. Macrophage presentation of TNP-Ficoll: Evidence for macrophage-B cell interaction
7. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions
8. CpG motifs in bacterial DNA trigger direct B-cell activation
9. CpG oligodeoxynucleotides rescue BKS-2 immature B cell lymphoma from anti-IgM-mediated growth inhibition by up-regulation of egr-1
10. Bacterial CpG DNA activates immune cells to signal infectious danger
11. Mitogenic synthetic polynucleotides suppress the antibody response to a bacterial polysaccharide
12. Capacity of CpG ODN to enhance TNP-Ficoll responses in mice
13. Synthetic oligodeoxynucleotide containing CpG motifs induces an anti-polysaccharide type 1-like immune response after immunization of mice with Haemophilus influenzae type b conjugate vaccine
14. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies
15. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice
16. CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming
17. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: Predominance of a Th2-biased pattern which persists after adult boosting
18. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: Comparative analysis of carbohydrate structures and the antigen presenting cell
19. The consequences of the intracellular retention of pathogen-derived T-cell-independent antigens on protein presentation to T cells
20. CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species
21. CpG oligodeoxynucleotides overcome the unresponsiveness of neonatal B cells to stimulation with the thymus-independent stimuli anti-IgM and TNP-Ficoll
22. Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor
23. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
24. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
25. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants
26. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization
27. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
28. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge
29. Marginal zone macrophages and their role in the immune response against T-independent type 2 antigens: Modulation of the cells with specific antibody
30. T cell regulation of IgG subclass antibody production in response to T-independent antigens
31. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen
32. Antibody response to pneumococcal polysaccharide vaccine in young, adult and old mice
33. Differential responses of B cells from the spleen and lymph node to TNP-Ficoll
34. Splenic dependence of the antibody response to thymus-independent (TI-2) antigens
35. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response
36. Studies on the induction of immunological unresponsiveness to pneumococcal polysaccharide in mice
37. Neonatal murine B lymphocytes respond to polysaccharide antigens in the presence of IL-1 and IL-6
38. Characterization of early activation events in cord blood B cells after stimulation with T cell-independent activators
39. Restoration of T cell-independent type 2 induction of Ig secretion by neonatal B cells in vitro